InfuSystem Holdings (INFU) Income from Continuing Operations (2010 - 2026)
InfuSystem Holdings (INFU) reported Income from Continuing Operations of 1000000.0 for Q1 2026, up 600.0% on a YoY basis from 142857.14 in Q1 2025, and down 51.5% quarter-over-quarter from 2062000.0 in Q4 2025.
InfuSystem Holdings (INFU) Income from Continuing Operations (2010 - 2026) Analysis & Trends
InfuSystem Holdings has reported Income from Continuing Operations for 17 years, with the latest figure at 1000000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations rose 600.0% year-over-year to 1000000.0; the trailing twelve-month figure through Mar 2026 stood at 7935000.0 (up 142.36% YoY), and the FY2025 full-year result was 6627000.0, up 182.6% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 1000000.0, down from 2062000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 2646000.0 in Q2 2025, with the low at 1112000.0 in Q1 2024.
- Historically, Income from Continuing Operations has averaged 647117.65 across 5 years, with a median of 443000.0 in 2022.
- The largest YoY upside for Income from Continuing Operations was 1879.17% in 2024 against a maximum downside of 243.21% in 2024.
- InfuSystem Holdings' Income from Continuing Operations stood at 107000.0 in 2022, then tumbled by 55.14% to 48000.0 in 2023, then jumped by 1879.17% to 950000.0 in 2024, then soared by 117.05% to 2062000.0 in 2025, then plunged by 51.5% to 1000000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 1000000.0 (Q1 2026), 2062000.0 (Q4 2025), and 2227000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | InfuSystem Holdings | 189.78 Mn | 187.68 Mn | 19.68 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 2.06 Mn |
| Sep 30, 2025 | 2.23 Mn |
| Jun 30, 2025 | 2.65 Mn |
| Mar 31, 2025 | -200,000.00 |
| Dec 31, 2024 | 950,000.00 |
| Sep 30, 2024 | 1.81 Mn |
| Jun 30, 2024 | 717,000.00 |
| Mar 31, 2024 | -1.11 Mn |
| Dec 31, 2023 | 48,000.00 |
| Sep 30, 2023 | 689,000.00 |
| Jun 30, 2023 | 435,000.00 |
| Mar 31, 2023 | -324,000.00 |
| Dec 31, 2022 | 107,000.00 |
| Sep 30, 2022 | 443,000.00 |
| Jun 30, 2022 | -164,000.00 |
| Mar 31, 2022 | -330,000.00 |
| Dec 31, 2021 | 361,000.00 |
| Sep 30, 2021 | -448,000.00 |
| Jun 30, 2021 | 820,000.00 |